J&J recalls ACUVUE lenses, reviews marketing activities (as per protocol)
Posted by Whiteboard Animators at octobre 24th, 2017
JJ’s ACUVUE has voluntarily recalled a limited number of its brand contact lenses due to unmet quality standards.
According to a press statement, the products impacted and distributed in Singapore is limited to 929 boxes, 0.03% of the total products sold since their release in the market. The recall affects products from its ACUVUE OASYS and ACUVUE OASYS for Astigmatism lines.
“At Johnson Johnson Vision, our top priority is patient safety and we hold ourselves to high standards for product quality and customer satisfaction,” the spokesperson added. When asked about the impact on marketing activities, the spokesperson explained that as part of its regular process, JJ reviews marketing activities and updates accordingly.
“As of today, we are working through this with our agency partners and internal teams,” the spokesperson said.
The JJ spokesperson said that no significant health risks have been reported due to the issues. Meanwhile, the company has taken measures to ensure the issues do not reoccur. It has also identified the root causes that led to the quality issues and has taken corrective measures to help ensure they do not recur.
As of yesterday, the company has also completed the retrieval of its affected products from optical stores and is working close with and quickly with the Health Sciences Authority, Singapore Optometric Association and eye care professionals.
In August, the company released an ad spot on YouTube promoting the ACUVUE OASYS 1-DAY Series. The spot featured a national bowler, national basketballer, and yoga instructor undergoing a vision challenge. The video garnered around 462,555 views on YouTube at the time of writing.
Most recently, the company released an ad starring local model Fiona Fussi. The video takes on a Korean theme and promotes JJ’s 1-Day ACUVUE DEFINE Radiant Sweet product. Since its launch on 11 October, the video garnered around 50,980 views on YouTube at the time of writing.